NovAccess Global Inc
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
Market Cap & Net Worth: NovAccess Global Inc (XSNX)
NovAccess Global Inc (PINK:XSNX) has a market capitalization of $2.72 ($2.72) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44633 globally and #14121 in its home market, demonstrating a 50.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NovAccess Global Inc's stock price $0.00 by its total outstanding shares 9053 (9.05K).
NovAccess Global Inc Market Cap History: 2015 to 2025
NovAccess Global Inc's market capitalization history from 2015 to 2025. Data shows change from $54.32 to $2.72 (-28.20% CAGR).
NovAccess Global Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NovAccess Global Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NovAccess Global Inc's market cap is 0.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
NovAccess Global Inc's market cap is 0.00 times its annual earnings
0.11x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $54.32 | $1.22 Million | -$1.32 Million | 0.00x | N/A |
| 2016 | $9.05 | $750.56K | -$242.87K | 0.00x | N/A |
| 2017 | $5.43 | $1.17 Million | -$498.66K | 0.00x | N/A |
| 2018 | $6.34 | $665.02K | -$3.97 Million | 0.00x | N/A |
| 2019 | $4.53 | $1.61 Million | $2.34 Million | 0.00x | 0.00x |
Competitor Companies of XSNX by Market Capitalization
Companies near NovAccess Global Inc in the global market cap rankings as of March 18, 2026.
Key companies related to NovAccess Global Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
NovAccess Global Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, NovAccess Global Inc's market cap moved from $54.32 to $ 2.72, with a yearly change of -28.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.72 | -96.67% |
| 2024 | $81.48 | -55.22% |
| 2023 | $181.97 | -93.07% |
| 2022 | $2.63K | -18.31% |
| 2021 | $3.21K | +4.11% |
| 2020 | $3.09K | +68100.00% |
| 2019 | $4.53 | -28.57% |
| 2018 | $6.34 | +16.67% |
| 2017 | $5.43 | -40.00% |
| 2016 | $9.05 | -83.33% |
| 2015 | $54.32 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NovAccess Global Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.72 USD |
| MoneyControl | $2.72 USD |
| MarketWatch | $2.72 USD |
| marketcap.company | $2.72 USD |
| Reuters | $2.72 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.